PELP1 and neoplasm: Compared with controls, mice treated with PELP1-siRNA-DOPC had a significant reduction in tumor volume by 58.6% (P < 0.001) (Figure 1B) without causing any observable signs of distress or changes in behavior, mobility or weight loss (data not shown), indicating low treatment toxicity.